Preterm Birth Prevention and Management Market Size, Share and Growth Outlook 2026: By Intervention Type, By Therapy, By Route of Administration, By Gestational-Age Risk Category, By End User, Companies to 2034
The global Preterm Birth Prevention and Management Market size is forecast to increase from $2 Billion in 2026 to $3.05 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.
The Preterm Birth Prevention and Management market report provides detailed analysis and outlook of Preterm Birth Prevention and Management segments including By Intervention Type (Therapeutics, Diagnostics and Screening Tools), By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytic Therapy, Magnesium Sulfate Therapy, Other Therapies ), By Route of Administration (Vaginal, Parenteral, Oral), By Gestational-Age Risk Category (Extremely Preterm, Very Preterm, Moderate-to-Late Preterm ), By End User (Hospitals, Maternity and Specialty Clinics, Home Healthcare Settings) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Preterm Birth Prevention and Management Industry Overview
Precision Risk Prediction, Biomarker-Based Diagnostics, and Neonatal Nutritional Optimization Are Transforming Preterm Birth Care
The preterm birth prevention and management industry is undergoing significant transformation as healthcare systems increasingly adopt predictive diagnostics, risk-stratified interventions, and personalized neonatal care strategies. Growing recognition of the long-term clinical and economic burden associated with premature birth is accelerating investments in biomarker-based screening technologies, point-of-care diagnostic pathways, and precision neonatal nutrition management. Healthcare providers are shifting from reactive treatment approaches toward proactive identification of maternal risk factors and individualized management protocols designed to improve maternal and neonatal outcomes.
Precision Biomarker Platforms Are Advancing Early Risk Identification
The adoption of predictive biomarker technologies is enabling clinicians to identify women at elevated risk of spontaneous preterm birth before clinical symptoms emerge. Precision medicine approaches are increasingly being integrated into routine obstetric care pathways to facilitate earlier intervention and individualized monitoring strategies. This trend is demonstrated by the continued expansion of the PreTRM blood test platform developed by Sera Prognostics, Inc.. The company's multi-protein biomarker assay enables clinicians to assess individualized risk for spontaneous preterm birth during weeks 18 to 20 of pregnancy, allowing earlier identification of asymptomatic high-risk pregnancies. The strategic focus on scaling precision pregnancy diagnostics reflects the broader movement toward predictive maternal-fetal medicine.
Diagnostic Supply Chain Challenges Are Reshaping Clinical Workflows
Supply chain disruptions affecting critical diagnostic products continue to influence clinical practice patterns and drive adoption of alternative testing pathways. Healthcare systems are increasingly implementing adaptive diagnostic protocols to maintain continuity of care during supply shortages. This trend is illustrated by the widespread restructuring of threatened preterm labor diagnostic pathways across the United Kingdom and Europe following manufacturing disruptions affecting fetal fibronectin testing supplies produced by Hologic. Clinical guidelines issued by national healthcare organizations prioritized remaining fetal fibronectin inventories for high-risk patients while encouraging the use of alternative biomarker platforms, such as Actim Partus, for symptomatic patient evaluation. These developments highlight the importance of diagnostic diversification and supply resilience in maternal healthcare.
Precision Neonatal Nutrition Is Improving Outcomes in Premature Infants
The management of preterm infants increasingly incorporates individualized nutritional strategies designed to support growth, neurological development, and long-term health outcomes. Advanced nutritional diagnostics are enabling neonatal intensive care units to optimize feeding protocols based on precise biochemical measurements. This trend is demonstrated by the expanded deployment and training initiatives surrounding the Human Milk Analyzer platform developed by Miris. The technology enables neonatal intensive care teams to measure macronutrient composition in breast milk and implement targeted nutritional fortification strategies for premature infants. The growing adoption of precision nutritional management reflects the increasing emphasis on personalized neonatal care within preterm birth management programs.
Preterm Birth Prevention and Management Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Preterm Birth Prevention and Management market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Ferring B.V., Hologic, Inc., The Cooper Companies, Inc., Covis Pharma GmbH, Pfizer Inc., Besins Healthcare, Takeda Pharmaceutical Company Limited, ObsEva SA, Merck & Co., Inc., QIAGEN N.V.. The Preterm Birth Prevention and Management market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Preterm Birth Prevention and Management industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Preterm Birth Prevention and Management industry include- Ferring B.V., Hologic, Inc., The Cooper Companies, Inc., Covis Pharma GmbH, Pfizer Inc., Besins Healthcare, Takeda Pharmaceutical Company Limited, ObsEva SA, Merck & Co., Inc., QIAGEN N.V.. The Preterm Birth Prevention and Management market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Preterm Birth Prevention and Management Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Preterm Birth Prevention and Management market remains one of the strongest-performing segments in the country.
The US Preterm Birth Prevention and Management Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Preterm Birth Prevention and Management market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Preterm Birth Prevention and Management industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Preterm Birth Prevention and Management markets
Canada's strong Preterm Birth Prevention and Management sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Preterm Birth Prevention and Management market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Preterm Birth Prevention and Management Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Preterm Birth Prevention and Management market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Preterm Birth Prevention and Management population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Preterm Birth Prevention and Management industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Preterm Birth Prevention and Management market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Preterm Birth Prevention and Management sales through 2034
France Preterm Birth Prevention and Management companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Preterm Birth Prevention and Management Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Preterm Birth Prevention and Management distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Preterm Birth Prevention and Management Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Preterm Birth Prevention and Management market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Preterm Birth Prevention and Management industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Preterm Birth Prevention and Management industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Preterm Birth Prevention and Management Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Preterm Birth Prevention and Management market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Preterm Birth Prevention and Management market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Preterm Birth Prevention and Management Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Preterm Birth Prevention and Management Market Segmentation
By Intervention Type
Therapeutics
Diagnostics and Screening Tools
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytic Therapy
Magnesium Sulfate Therapy
Other Therapies
By Route of Administration
Vaginal
Parenteral
Oral
By Gestational-Age Risk Category
Extremely Preterm
Very Preterm
Moderate-to-Late Preterm
By End User
Hospitals
Maternity and Specialty Clinics
Home Healthcare Settings
Leading Companies in Preterm Birth Prevention and Management Industry (2026)
Ferring B.V.
Hologic, Inc.
The Cooper Companies, Inc.
Covis Pharma GmbH
Pfizer Inc.
Besins Healthcare
Takeda Pharmaceutical Company Limited
ObsEva SA
Merck & Co., Inc.
QIAGEN N.V.
Countries Included
The Preterm Birth Prevention and Management market report provides detailed analysis and outlook of Preterm Birth Prevention and Management segments including By Intervention Type (Therapeutics, Diagnostics and Screening Tools), By Therapy (Progesterone Therapy, Corticosteroid Therapy, Tocolytic Therapy, Magnesium Sulfate Therapy, Other Therapies ), By Route of Administration (Vaginal, Parenteral, Oral), By Gestational-Age Risk Category (Extremely Preterm, Very Preterm, Moderate-to-Late Preterm ), By End User (Hospitals, Maternity and Specialty Clinics, Home Healthcare Settings) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Preterm Birth Prevention and Management Industry Overview
Precision Risk Prediction, Biomarker-Based Diagnostics, and Neonatal Nutritional Optimization Are Transforming Preterm Birth Care
The preterm birth prevention and management industry is undergoing significant transformation as healthcare systems increasingly adopt predictive diagnostics, risk-stratified interventions, and personalized neonatal care strategies. Growing recognition of the long-term clinical and economic burden associated with premature birth is accelerating investments in biomarker-based screening technologies, point-of-care diagnostic pathways, and precision neonatal nutrition management. Healthcare providers are shifting from reactive treatment approaches toward proactive identification of maternal risk factors and individualized management protocols designed to improve maternal and neonatal outcomes.
Precision Biomarker Platforms Are Advancing Early Risk Identification
The adoption of predictive biomarker technologies is enabling clinicians to identify women at elevated risk of spontaneous preterm birth before clinical symptoms emerge. Precision medicine approaches are increasingly being integrated into routine obstetric care pathways to facilitate earlier intervention and individualized monitoring strategies. This trend is demonstrated by the continued expansion of the PreTRM blood test platform developed by Sera Prognostics, Inc.. The company's multi-protein biomarker assay enables clinicians to assess individualized risk for spontaneous preterm birth during weeks 18 to 20 of pregnancy, allowing earlier identification of asymptomatic high-risk pregnancies. The strategic focus on scaling precision pregnancy diagnostics reflects the broader movement toward predictive maternal-fetal medicine.
Diagnostic Supply Chain Challenges Are Reshaping Clinical Workflows
Supply chain disruptions affecting critical diagnostic products continue to influence clinical practice patterns and drive adoption of alternative testing pathways. Healthcare systems are increasingly implementing adaptive diagnostic protocols to maintain continuity of care during supply shortages. This trend is illustrated by the widespread restructuring of threatened preterm labor diagnostic pathways across the United Kingdom and Europe following manufacturing disruptions affecting fetal fibronectin testing supplies produced by Hologic. Clinical guidelines issued by national healthcare organizations prioritized remaining fetal fibronectin inventories for high-risk patients while encouraging the use of alternative biomarker platforms, such as Actim Partus, for symptomatic patient evaluation. These developments highlight the importance of diagnostic diversification and supply resilience in maternal healthcare.
Precision Neonatal Nutrition Is Improving Outcomes in Premature Infants
The management of preterm infants increasingly incorporates individualized nutritional strategies designed to support growth, neurological development, and long-term health outcomes. Advanced nutritional diagnostics are enabling neonatal intensive care units to optimize feeding protocols based on precise biochemical measurements. This trend is demonstrated by the expanded deployment and training initiatives surrounding the Human Milk Analyzer platform developed by Miris. The technology enables neonatal intensive care teams to measure macronutrient composition in breast milk and implement targeted nutritional fortification strategies for premature infants. The growing adoption of precision nutritional management reflects the increasing emphasis on personalized neonatal care within preterm birth management programs.
Preterm Birth Prevention and Management Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Preterm Birth Prevention and Management market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Ferring B.V., Hologic, Inc., The Cooper Companies, Inc., Covis Pharma GmbH, Pfizer Inc., Besins Healthcare, Takeda Pharmaceutical Company Limited, ObsEva SA, Merck & Co., Inc., QIAGEN N.V.. The Preterm Birth Prevention and Management market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Preterm Birth Prevention and Management industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Preterm Birth Prevention and Management Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Preterm Birth Prevention and Management companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Preterm Birth Prevention and Management markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Preterm Birth Prevention and Management industry include- Ferring B.V., Hologic, Inc., The Cooper Companies, Inc., Covis Pharma GmbH, Pfizer Inc., Besins Healthcare, Takeda Pharmaceutical Company Limited, ObsEva SA, Merck & Co., Inc., QIAGEN N.V.. The Preterm Birth Prevention and Management market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Preterm Birth Prevention and Management Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Preterm Birth Prevention and Management market remains one of the strongest-performing segments in the country.
The US Preterm Birth Prevention and Management Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Preterm Birth Prevention and Management market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Preterm Birth Prevention and Management industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Preterm Birth Prevention and Management markets
Canada's strong Preterm Birth Prevention and Management sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Preterm Birth Prevention and Management market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Preterm Birth Prevention and Management Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Preterm Birth Prevention and Management market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Preterm Birth Prevention and Management population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Preterm Birth Prevention and Management industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Preterm Birth Prevention and Management market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Preterm Birth Prevention and Management sales through 2034
France Preterm Birth Prevention and Management companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Preterm Birth Prevention and Management Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Preterm Birth Prevention and Management distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Preterm Birth Prevention and Management Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Preterm Birth Prevention and Management market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Preterm Birth Prevention and Management industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Preterm Birth Prevention and Management industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Preterm Birth Prevention and Management Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Preterm Birth Prevention and Management market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Preterm Birth Prevention and Management market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Preterm Birth Prevention and Management Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Preterm Birth Prevention and Management Market Segmentation
By Intervention Type
Therapeutics
Diagnostics and Screening Tools
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytic Therapy
Magnesium Sulfate Therapy
Other Therapies
By Route of Administration
Vaginal
Parenteral
Oral
By Gestational-Age Risk Category
Extremely Preterm
Very Preterm
Moderate-to-Late Preterm
By End User
Hospitals
Maternity and Specialty Clinics
Home Healthcare Settings
Leading Companies in Preterm Birth Prevention and Management Industry (2026)
Ferring B.V.
Hologic, Inc.
The Cooper Companies, Inc.
Covis Pharma GmbH
Pfizer Inc.
Besins Healthcare
Takeda Pharmaceutical Company Limited
ObsEva SA
Merck & Co., Inc.
QIAGEN N.V.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Preterm Birth Prevention and Management Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Preterm Birth Prevention and Management Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Preterm Birth Prevention and Management Markets in 2026
3.2. Global Historic and Forecast Preterm Birth Prevention and Management Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Preterm Birth Prevention and Management Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Preterm Birth Prevention and Management Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Preterm Birth Prevention and Management Value Chain
CHAPTER 4- PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Preterm Birth Prevention and Management Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Intervention Type
Therapeutics
Diagnostics and Screening Tools
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytic Therapy
Magnesium Sulfate Therapy
Other Therapies
By Route of Administration
Vaginal
Parenteral
Oral
By Gestational-Age Risk Category
Extremely Preterm
Very Preterm
Moderate-to-Late Preterm
By End User
Hospitals
Maternity and Specialty Clinics
Home Healthcare Settings
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Preterm Birth Prevention and Management Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
7.5. North America Preterm Birth Prevention and Management Market Size Outlook by Type
7.6. North America Preterm Birth Prevention and Management Market Size Outlook by Application
7.7. North America Preterm Birth Prevention and Management Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Preterm Birth Prevention and Management Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Preterm Birth Prevention and Management Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Preterm Birth Prevention and Management Companies
CHAPTER 8- EUROPE PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Preterm Birth Prevention and Management Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
8.5. Europe Preterm Birth Prevention and Management Market Size Outlook by Type
8.6. Europe Preterm Birth Prevention and Management Market Size Outlook by Application
8.7. Europe Preterm Birth Prevention and Management Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Preterm Birth Prevention and Management Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Preterm Birth Prevention and Management Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Preterm Birth Prevention and Management Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Preterm Birth Prevention and Management Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Preterm Birth Prevention and Management Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Preterm Birth Prevention and Management Companies
CHAPTER 9- ASIA PACIFIC PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Preterm Birth Prevention and Management Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Type
9.6. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Application
9.7. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Preterm Birth Prevention and Management Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Preterm Birth Prevention and Management Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Preterm Birth Prevention and Management Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Preterm Birth Prevention and Management Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Preterm Birth Prevention and Management Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Preterm Birth Prevention and Management Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Preterm Birth Prevention and Management Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
10.5. South and Central America Preterm Birth Prevention and Management Market Size Outlook by Type
10.6. South and Central America Preterm Birth Prevention and Management Market Size Outlook by Application
10.7. South and Central America Preterm Birth Prevention and Management Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Preterm Birth Prevention and Management Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Preterm Birth Prevention and Management Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Preterm Birth Prevention and Management Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Preterm Birth Prevention and Management Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook by Type
11.6. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook by Application
11.7. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Preterm Birth Prevention and Management Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Preterm Birth Prevention and Management Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Preterm Birth Prevention and Management Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Preterm Birth Prevention and Management Industry
Ferring B.V.
Hologic, Inc.
The Cooper Companies, Inc.
Covis Pharma GmbH
Pfizer Inc.
Besins Healthcare
Takeda Pharmaceutical Company Limited
ObsEva SA
Merck & Co., Inc.
QIAGEN N.V.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Preterm Birth Prevention and Management Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Preterm Birth Prevention and Management Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Preterm Birth Prevention and Management Markets in 2026
3.2. Global Historic and Forecast Preterm Birth Prevention and Management Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Preterm Birth Prevention and Management Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Preterm Birth Prevention and Management Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Preterm Birth Prevention and Management Value Chain
CHAPTER 4- PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Preterm Birth Prevention and Management Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Intervention Type
Therapeutics
Diagnostics and Screening Tools
By Therapy
Progesterone Therapy
Corticosteroid Therapy
Tocolytic Therapy
Magnesium Sulfate Therapy
Other Therapies
By Route of Administration
Vaginal
Parenteral
Oral
By Gestational-Age Risk Category
Extremely Preterm
Very Preterm
Moderate-to-Late Preterm
By End User
Hospitals
Maternity and Specialty Clinics
Home Healthcare Settings
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Preterm Birth Prevention and Management Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
7.5. North America Preterm Birth Prevention and Management Market Size Outlook by Type
7.6. North America Preterm Birth Prevention and Management Market Size Outlook by Application
7.7. North America Preterm Birth Prevention and Management Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Preterm Birth Prevention and Management Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Preterm Birth Prevention and Management Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Preterm Birth Prevention and Management Companies
CHAPTER 8- EUROPE PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Preterm Birth Prevention and Management Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
8.5. Europe Preterm Birth Prevention and Management Market Size Outlook by Type
8.6. Europe Preterm Birth Prevention and Management Market Size Outlook by Application
8.7. Europe Preterm Birth Prevention and Management Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Preterm Birth Prevention and Management Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Preterm Birth Prevention and Management Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Preterm Birth Prevention and Management Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Preterm Birth Prevention and Management Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Preterm Birth Prevention and Management Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Preterm Birth Prevention and Management Companies
CHAPTER 9- ASIA PACIFIC PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Preterm Birth Prevention and Management Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Type
9.6. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Application
9.7. Asia Pacific Preterm Birth Prevention and Management Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Preterm Birth Prevention and Management Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Preterm Birth Prevention and Management Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Preterm Birth Prevention and Management Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Preterm Birth Prevention and Management Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Preterm Birth Prevention and Management Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Preterm Birth Prevention and Management Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Preterm Birth Prevention and Management Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
10.5. South and Central America Preterm Birth Prevention and Management Market Size Outlook by Type
10.6. South and Central America Preterm Birth Prevention and Management Market Size Outlook by Application
10.7. South and Central America Preterm Birth Prevention and Management Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Preterm Birth Prevention and Management Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Preterm Birth Prevention and Management Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Preterm Birth Prevention and Management Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PRETERM BIRTH PREVENTION AND MANAGEMENT MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Preterm Birth Prevention and Management Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Preterm Birth Prevention and Management Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook by Type
11.6. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook by Application
11.7. Middle East and Africa Preterm Birth Prevention and Management Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Preterm Birth Prevention and Management Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Preterm Birth Prevention and Management Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Preterm Birth Prevention and Management Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Preterm Birth Prevention and Management Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Preterm Birth Prevention and Management Industry
Ferring B.V.
Hologic, Inc.
The Cooper Companies, Inc.
Covis Pharma GmbH
Pfizer Inc.
Besins Healthcare
Takeda Pharmaceutical Company Limited
ObsEva SA
Merck & Co., Inc.
QIAGEN N.V.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
